The Chemours Company (NYSE:CC) Receives $33.10 Average Price Target from Analysts

The Chemours Company (NYSE:CCGet Free Report) has received an average rating of “Hold” from the seven brokerages that are currently covering the stock, MarketBeat reports. Five analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. The average twelve-month price target among brokers that have issued a report on the stock in the last year is $32.89.

A number of research firms recently issued reports on CC. Royal Bank of Canada upgraded Chemours from a “sector perform” rating to an “outperform” rating and boosted their price objective for the company from $28.00 to $40.00 in a research report on Friday, December 1st. The Goldman Sachs Group cut their price objective on Chemours from $35.00 to $30.00 and set a “neutral” rating for the company in a report on Tuesday, October 31st. Morgan Stanley cut their price objective on Chemours from $33.00 to $28.00 and set an “equal weight” rating for the company in a report on Monday, October 30th. Barclays cut their target price on Chemours from $31.00 to $28.00 and set an “equal weight” rating on the stock in a research report on Monday, October 30th. Finally, BMO Capital Markets cut their target price on Chemours from $45.00 to $39.00 and set an “outperform” rating on the stock in a research report on Monday, October 30th.

Check Out Our Latest Analysis on Chemours

Chemours Price Performance

Shares of NYSE CC opened at $31.19 on Thursday. Chemours has a twelve month low of $22.88 and a twelve month high of $39.05. The company has a current ratio of 1.68, a quick ratio of 1.08 and a debt-to-equity ratio of 5.21. The company has a market capitalization of $4.63 billion, a price-to-earnings ratio of -15.07 and a beta of 2.08. The business has a 50 day simple moving average of $30.53 and a 200-day simple moving average of $29.80.

Hedge Funds Weigh In On Chemours

A number of hedge funds have recently modified their holdings of the stock. Brown Brothers Harriman & Co. grew its stake in shares of Chemours by 7.0% in the 2nd quarter. Brown Brothers Harriman & Co. now owns 5,504 shares of the specialty chemicals company’s stock valued at $203,000 after buying an additional 360 shares during the period. Creative Planning boosted its stake in Chemours by 2.9% during the 4th quarter. Creative Planning now owns 13,601 shares of the specialty chemicals company’s stock valued at $416,000 after purchasing an additional 379 shares during the last quarter. Invst LLC boosted its stake in Chemours by 1.7% during the 2nd quarter. Invst LLC now owns 22,306 shares of the specialty chemicals company’s stock valued at $823,000 after purchasing an additional 380 shares during the last quarter. Baird Financial Group Inc. boosted its stake in Chemours by 4.3% during the 1st quarter. Baird Financial Group Inc. now owns 10,390 shares of the specialty chemicals company’s stock valued at $327,000 after purchasing an additional 426 shares during the last quarter. Finally, Modera Wealth Management LLC boosted its stake in Chemours by 4.6% during the 2nd quarter. Modera Wealth Management LLC now owns 10,547 shares of the specialty chemicals company’s stock valued at $389,000 after purchasing an additional 466 shares during the last quarter. 76.46% of the stock is owned by institutional investors and hedge funds.

About Chemours

(Get Free Report

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.

Further Reading

Analyst Recommendations for Chemours (NYSE:CC)

Receive News & Ratings for Chemours Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemours and related companies with MarketBeat.com's FREE daily email newsletter.